ACS Medicinal Chemistry Letters · 2020 · 10 citations · 20 references
Life SciencesCell BiologyPharmacologyCancer PharmacologyCell SignalingSignal TransductionCancer Cell SignalingGibberellin BiologyGibberellin Signal TransductionKinase Signaling InhibitorsNuclear Factor Kappa B ModulationNuclear Factor Kappa B SignalingNuclear Translocation Of Transcription Factors
The small molecule gibberellin JRA-003 was identified as an inhibitor of the NF-kB (nuclear kappa-light-chain-enhancer of activated B cells) pathway. Here we find that JRA-003 binds to and significantly inhibits the nuclear translocation of pathway-activating kinases IKKα (IκB kinase alpha) and IKKβ (IκB kinase beta). Analogs of JRA-003 were synthesized and NF-κB-inhibiting gibberellins were found to be cytotoxic in cancer-derived cell lines (HS 578T, HCC 1599, RC-K8, Sud-HL4, CA 46, and NCIH 4466). Not only was JRA-003 identified as the most potent synthetic gibberellin against cancer-derived cell lines, it displayed no cytotoxicity in cells derived from noncancerous sources (HEK 293T, HS 578BST, HS 888Lu, HS 895Sk, HUVEC). This selectivity suggests a promising approach for the development of new therapeutics.
20
NF-κB is a target of AKT in anti-apoptotic PDGF signalling
Julia A. Romashkova, Sergei S. Makarov · Nature · 1999 · 1.8K citations
Paul Jackson, John C. Widen, Daniel A. Harki et al. · Journal of Medicinal Chemistry · 2016 · 548 citations · Full text
Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin
Jun‐Li Luo, Wei Phin Tan, Jill M. Ricono et al. · Nature · 2007 · 439 citations